| 2024-01-17 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 18,276 0.0075% | $0.67 | $12,300 | +61.54% | |
| 2024-01-16 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 2,287 0.0011% | $0.79 | $1,807 | +61.95% | |
| 2024-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 7,799 0.0035% | $0.85 | $6,661 | +39.46% | |
| 2024-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 4,009 0.0017% | $0.84 | $3,354 | +33.35% | |
| 2023-01-17 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 2,159 0.0014% | $1.86 | $4,011 | -47.31% | |
| 2023-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 7,449 0.0042% | $1.71 | $12,708 | -49.29% | |
| 2023-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 3,843 0.0023% | $1.75 | $6,713 | -48.1% | |
| 2023-01-04 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 876 0.0005% | $1.69 | $1,484 | -47.5% | |
| 2022-01-18 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 2,121 0.0014% | $3.19 | $6,770 | -40.52% | |
| 2022-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 854 0.0006% | $3.54 | $3,027 | -46.49% | |
| 2022-01-11 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 3,770 0.0024% | $3.56 | $13,409 | -48.88% | |
| 2022-01-04 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 849 0.0006% | $4.06 | $3,451 | -52.08% | |
| 2021-01-19 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 2,111 0.0013% | $5.67 | $11,968 | -16.67% | |
| 2021-01-12 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 841 0.0006% | $6.15 | $5,174 | -15.45% | |
| 2021-01-04 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 845 0.0005% | $5.33 | $4,502 | -16.14% | |
| 2020-01-14 | Sale | Adaptimmune Therapeutics plc ADAP | Chief Medical Officer | 911 0.0009% | $5.13 | $4,678 | +28.47% |